Perhaps confirmation bias but I am super confident
AM session - FDA concerns about potency however no one came up with options for better assays. So there is acknowledgement that its not a perfect system. One of the panel stated that you could gather more data/do more trials to try to find a better marker, but in a years time, you could still not know. MSB indicated they were committed to continue to analyse/gather data etc and continue to improve. The only suggestion made on improvements was transcriptome sequencing. So IMO, no show stoppers, probably a few post-marketing commitments
PM session - none of the clarifying questions from panel were towards the FDA questions - aside from the comment that FDA allowed single arm trial for ruxtolimb and what's the difference with MSB, and a couple of questions on why Dr Kurtzberg wouldn't be comfortable with a double blind trial. General agreement that the remestemcel works, is safe with most questions on durability of response, steroid weaning, etc.
Cant see any reason atm for any of the panel to vote against MSB.
- Forums
- ASX - By Stock
- MSB
- Ryoncil: ODAC/FDA Meeting Discussion
Ryoncil: ODAC/FDA Meeting Discussion, page-1159
-
-
- There are more pages in this discussion • 888 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
99.0¢ |
Change
0.030(3.13%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
96.5¢ | $1.03 | 96.5¢ | $4.704M | 4.708M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 87395 | 98.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 274051 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 87395 | 0.985 |
3 | 116426 | 0.980 |
2 | 84419 | 0.975 |
3 | 54211 | 0.970 |
5 | 98141 | 0.965 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 274051 | 2 |
1.005 | 49212 | 4 |
1.010 | 31212 | 2 |
1.015 | 72652 | 4 |
1.020 | 560 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |